BRGX
BIOREGENX, INC.Company Information
- Company Name
- BIOREGENX, INC.
- CIK
- CIK0001593184
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- BRGX: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 06 Technology
- SIC
- 7370
- SIC Description
- Services-Computer Programming, Data Processing, Etc.
- Ticker
- BRGX
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-05-20
- Price on filing date
- —
- 1-month reaction
- -7.78%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Investments | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | ||||||
| Assets Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Notes And Loans Receivable Net Noncurrent | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Other Accounts Payable And Accrued Liabilities | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Other Long Term Debt Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | - | - | 1 | 1 | - | 0 | 10 | 10 | 11 | 0 | 0 | 0 | ||||||
| Other Notes Payable Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Goodwill | - | - | - | - | - | - | 7 | 7 | 7 | - | - | - | ||||||
| Assets | 0 | 0 | 1 | 1 | 0 | 1 | 17 | 18 | 19 | 1 | 0 | 0 | ||||||
| Long Term Debt Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Accounts Payable Current | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 0 | 0 | ||||||
| Interest Payable Current | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Notes And Loans Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | - | - | ||||||
| Deferred Revenue Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Finite Lived Intangible Assets Accumulated Amortization | - | - | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Long Term Notes Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Liabilities | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 0 | 0 | ||||||
| Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | ||||||
| Preferred Stock Value | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Additional Paid In Capital | 32 | 32 | 31 | 31 | 31 | 31 | 30 | 30 | 30 | 10 | 3 | 3 | ||||||
| Retained Earnings Accumulated Deficit | -37 | -37 | -36 | -36 | -36 | -36 | -17 | -17 | -16 | -13 | -3 | -3 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | 0 | - | -0 | -0 | 0 | -0 | 0 | 0 | -0 | - | - | ||||||
| Stockholders Equity | -5 | -5 | -4 | -4 | -4 | -3 | 14 | 14 | 15 | -2 | -3 | -3 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 1 | 1 | 0 | 1 | 17 | 18 | 19 | 1 | 0 | 0 | ||||||
| Debt Default Shortterm Debt Amount | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 972 | 969 | 962 | 961 | 960 | 957 | 957 | 957 | 957 | 771 | 277 | 277 | ||||||
| Shares Outstanding | 972 | 969 | 962 | 961 | 960 | 957 | 957 | 957 | 957 | 771 | 277 | 277 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBIOREGENX, INC. (BRGX) — SEC Financial Statements & Analysis
BIOREGENX, INC. (BRGX) is a services-computer programming, data processing, etc. company, incorporated in NV. BIOREGENX, INC. trades on OTC as: BRGX. BIOREGENX, INC. (BRGX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-20. Based on that filing, BIOREGENX, INC. carries a market cap of $11.23M, a P/E ratio of -8.62x, a P/B ratio of -2.48x, a P/S ratio of 6.36x, an enterprise value of $11.37M, and an EV/EBITDA multiple of -10.95x. On profitability, it posts a gross margin of 81.90%, an operating margin of -62.37%, a net margin of -73.81%, a Return on Equity (ROE) of 32.21%, a Return on Assets (ROA) of -317.96%, and a Return on Invested Capital (ROIC) of -84.52%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -23.43% year-over-year, net income growth of -93.54% year-over-year, and EPS growth of -93.62% year-over-year. On the balance sheet, it maintains a current ratio of 0.05x, a quick ratio of 0.02x, working capital of $-3.80M, a debt-to-equity ratio of -1.07x, a debt ratio of 14.45, an interest coverage ratio of -13.25x, free cash flow of $-31.15K (TTM), and net debt of $136.76K. Figures sourced from SEC EDGAR.
- Market Cap
- $11.23M
- P/E TTM
- -8.62x
- EPS TTM
- $-0.00
- P/B TTM
- -2.48x
- ROE TTM
- 32.21%
- ROA TTM
- -317.96%
- Debt To Equity
- -1.07x
- Free Cash Flow TTM
- $-31.15K
- Net Revenue TTM Growth 1Y
- -23.43%
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BIOREGENX, INC. in?
BIOREGENX, INC. (BRGX) operates in the Services-Computer Programming, Data Processing, Etc. industry.
What exchange does BRGX trade on?
BIOREGENX, INC. (BRGX) trades on the OTC.
Where is BIOREGENX, INC. incorporated?
BIOREGENX, INC. is incorporated in NV.
When was BIOREGENX, INC. (BRGX)'s most recent SEC filing?
BIOREGENX, INC. (BRGX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-20.
What is BRGX's market cap?
BIOREGENX, INC. (BRGX) has a market capitalization of $11.23M as of 2026-03-31.
What is BRGX's EPS (earnings per share)?
BIOREGENX, INC. (BRGX)'s trailing twelve month EPS is $-0.00 as of 2026-03-31.
What is BRGX's ROE (return on equity)?
BIOREGENX, INC. (BRGX)'s trailing twelve month Return on Equity (ROE) is 32.21% as of 2026-03-31.
What is BRGX's ROA (return on assets)?
BIOREGENX, INC. (BRGX)'s trailing twelve month Return on Assets (ROA) is -317.96% as of 2026-03-31.
What is BRGX's ROIC (return on invested capital)?
BIOREGENX, INC. (BRGX)'s trailing twelve month Return on Invested Capital (ROIC) is -84.52% as of 2024-09-30.
What is BRGX's EV/EBITDA?
BIOREGENX, INC. (BRGX)'s trailing twelve month EV/EBITDA is -10.95x as of 2026-03-31.